Finanzen von Splash Beverage Group Inc (SBEV)SBEVSplash Beverage Group Inc

Endovia Health Sciences, Inc. (SBEV) generates its revenue primarily from Splash Beverage Group, which accounts for 100.0% of total sales, equivalent to $4.22K. Understanding this concentration is critical for investors evaluating how SBEV navigates market cycles within the Non-Alcoholic Beverages industry.

Evaluating the bottom line, Endovia Health Sciences, Inc. maintains a gross margin of 43.75%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -70699.24%, while the net margin is -97028.17%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively SBEV converts its operational activities into shareholder value.

In the context of the broader market, SBEV competes directly with industry leaders such as IVF and NIVF. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, SBEV's gross margin of 43.75% stands against IVF's 28.37% and NIVF's 36.79%. Such benchmarking helps identify whether Endovia Health Sciences, Inc. is trading at a premium or discount relative to its financial performance.

The company reported a gross margin of 43.75% in Q1 2026, indicating improved profitability despite ongoing losses. However, total revenue has been declining, with only 4,224 USD reported in Q1 2026.